GluToTrackGlucose Tolerance Tracking in Non-Insulin Treated Type 2 Diabetes Patients

Diabetes, particularly Type 2 Diabetes (T2D), is a rapidly growing health issue worldwide. This study aims to support people with T2D who are not using insulin by helping them track how their bodies handle glucose. The focus is on how lifestyle changes, like exercise and diet, can not only manage but potentially reverse the progression of T2D. The study uses technology, such as continuous glucose monitoring (CGM) devices and smartphones, to provide real-time feedback and education. This approach can empower patients to better manage their condition and help healthcare providers monitor disease progression and treatment effectiveness. In the study, 20 participants aged between 40 and 70 years who are not physically active and do not use insulin will use wearable technology, including CGM devices and activity trackers. For one week, they will continue their usual sedentary lifestyle, and during the second week, they will increase their activity to at least 10,000 steps per day. This involves replacing sitting with light walking, totaling at least 150 minutes of activity per week. At the start and end of each week, participants will undergo a meal test to measure glucose, insulin, and C-peptide levels in their blood. This will help evaluate how the increased physical activity impacts their glucose tolerance, providing insights into the effectiveness of lifestyle changes in managing T2D.